NCT02800161View on ClinicalTrials.gov

Trehalose as add-on Therapy in Bipolar Depression

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Bipolar DisorderBipolar Depression
Interventions
DRUG

Trehalose

Trehalose 70g/die

DRUG

Maltose

Maltose 70g/die

Trial Locations (1)

08036

Hospital Clinic of Barcelona, Barcelona

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Consorcio Centro de Investigación Biomédica en Red (CIBER)

OTHER_GOV

NCT02800161 - Trehalose as add-on Therapy in Bipolar Depression | Biotech Hunter | Biotech Hunter